The consideration of the σ2-R/PGRMC1 complex as a key regulator of Aβ1-42 oligomer and apoE accumulation in the cell has led to the conclusion that it may be of clinical significance in the treatment of Alzheimer’s disease. Here, TMEM97 is linked to Alzheimer disease.